These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 22850268)
1. The efficacy and safety of 12 weeks of treatment with sertindole or olanzapine in patients with chronic schizophrenia who did not respond successfully to their previous treatments: a randomized, double-blind, parallel-group, flexible-dose study. Kwon JS; Mittoux A; Hwang JY; Ong A; Cai ZJ; Su TP Int Clin Psychopharmacol; 2012 Nov; 27(6):326-35. PubMed ID: 22850268 [TBL] [Abstract][Full Text] [Related]
2. A double-blind, controlled study of sertindole versus risperidone in the treatment of moderate-to-severe schizophrenia. Azorin JM; Strub N; Loft H Int Clin Psychopharmacol; 2006 Jan; 21(1):49-56. PubMed ID: 16317317 [TBL] [Abstract][Full Text] [Related]
3. Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group. Zimbroff DL; Kane JM; Tamminga CA; Daniel DG; Mack RJ; Wozniak PJ; Sebree TB; Wallin BA; Kashkin KB Am J Psychiatry; 1997 Jun; 154(6):782-91. PubMed ID: 9167505 [TBL] [Abstract][Full Text] [Related]
4. Randomized, controlled, double-blind multicenter comparison of the efficacy and tolerability of ziprasidone and olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder. Simpson GM; Glick ID; Weiden PJ; Romano SJ; Siu CO Am J Psychiatry; 2004 Oct; 161(10):1837-47. PubMed ID: 15465981 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of sertindole in schizophrenia: a clinical review. Zoccali RA; Bruno A; Muscatello MR J Clin Psychopharmacol; 2015 Jun; 35(3):286-95. PubMed ID: 25830594 [TBL] [Abstract][Full Text] [Related]
7. Olanzapine versus placebo in adolescents with schizophrenia: a 6-week, randomized, double-blind, placebo-controlled trial. Kryzhanovskaya L; Schulz SC; McDougle C; Frazier J; Dittmann R; Robertson-Plouch C; Bauer T; Xu W; Wang W; Carlson J; Tohen M J Am Acad Child Adolesc Psychiatry; 2009 Jan; 48(1):60-70. PubMed ID: 19057413 [TBL] [Abstract][Full Text] [Related]
8. Long-term efficacy and safety comparison of sertindole and haloperidol in the treatment of schizophrenia. The Sertindole Study Group. Daniel DG; Wozniak P; Mack RJ; McCarthy BG Psychopharmacol Bull; 1998; 34(1):61-9. PubMed ID: 9564200 [TBL] [Abstract][Full Text] [Related]
9. Drug safety and efficacy evaluation of sertindole for schizophrenia. Karamatskos E; Lambert M; Mulert C; Naber D Expert Opin Drug Saf; 2012 Nov; 11(6):1047-62. PubMed ID: 22992213 [TBL] [Abstract][Full Text] [Related]
10. Sertindole in the long-term treatment of schizophrenia. Hale AS; Azorin JM; Lemming OM; Mæhlum E Int Clin Psychopharmacol; 2012 Jul; 27(4):231-7. PubMed ID: 22609816 [TBL] [Abstract][Full Text] [Related]
11. Sertindole: efficacy and safety in schizophrenia. Lindström E; Levander S Expert Opin Pharmacother; 2006 Sep; 7(13):1825-34. PubMed ID: 16925508 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: a randomized, double-blind 52-week comparison. McEvoy JP; Lieberman JA; Perkins DO; Hamer RM; Gu H; Lazarus A; Sweitzer D; Olexy C; Weiden P; Strakowski SD Am J Psychiatry; 2007 Jul; 164(7):1050-60. PubMed ID: 17606657 [TBL] [Abstract][Full Text] [Related]
13. Cardiac effects of sertindole and quetiapine: analysis of ECGs from a randomized double-blind study in patients with schizophrenia. Nielsen J; Matz J; Mittoux A; Polcwiartek C; Struijk JJ; Toft E; Kanters JK; Graff C Eur Neuropsychopharmacol; 2015 Mar; 25(3):303-11. PubMed ID: 25583364 [TBL] [Abstract][Full Text] [Related]
14. Divalproex ER combined with olanzapine or risperidone for treatment of acute exacerbations of schizophrenia. Casey DE; Daniel DG; Tamminga C; Kane JM; Tran-Johnson T; Wozniak P; Abi-Saab W; Baker J; Redden L; Greco N; Saltarelli M Neuropsychopharmacology; 2009 Apr; 34(5):1330-8. PubMed ID: 19052541 [TBL] [Abstract][Full Text] [Related]
15. A review of the efficacy, tolerability and safety of sertindole in clinical trials. Perquin L; Steinert T CNS Drugs; 2004; 18 Suppl 2():19-30; discussion 41-3. PubMed ID: 15461313 [TBL] [Abstract][Full Text] [Related]
16. Sertindole: dilemmas for its use in clinical practice. Pae CU Expert Opin Drug Saf; 2013 May; 12(3):321-6. PubMed ID: 23432404 [TBL] [Abstract][Full Text] [Related]
17. Lurasidone in the treatment of schizophrenia: a randomized, double-blind, placebo- and olanzapine-controlled study. Meltzer HY; Cucchiaro J; Silva R; Ogasa M; Phillips D; Xu J; Kalali AH; Schweizer E; Pikalov A; Loebel A Am J Psychiatry; 2011 Sep; 168(9):957-67. PubMed ID: 21676992 [TBL] [Abstract][Full Text] [Related]
18. Olanzapine versus aripiprazole for the treatment of agitation in acutely ill patients with schizophrenia. Kinon BJ; Stauffer VL; Kollack-Walker S; Chen L; Sniadecki J J Clin Psychopharmacol; 2008 Dec; 28(6):601-7. PubMed ID: 19011427 [TBL] [Abstract][Full Text] [Related]
19. Double-blind, randomized comparison of olanzapine versus fluphenazine in the long-term treatment of schizophrenia. Dossenbach MR; Folnegovic-Smalc V; Hotujac L; Uglesic B; Tollefson GD; Grundy SL; Friedel P; Jakovljevic MM; Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):311-8. PubMed ID: 14751428 [TBL] [Abstract][Full Text] [Related]
20. A double-blind, randomized study comparing the efficacy and safety of sertindole and risperidone in patients with treatment-resistant schizophrenia. Kane JM; Potkin SG; Daniel DG; Buckley PF J Clin Psychiatry; 2011 Feb; 72(2):194-204. PubMed ID: 20673553 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]